Miles Education Hosts India’s First-Ever Public Accounting GCC Conclave (M-PACT), Cementing India’s Role as a Global Accounting Powerhouse
BENGALURU, India, Dec. 20, 2024 /PRNewswire/ -- Miles Education, the flagbearer of…
Amwell CFO Mark Hirschhorn Expands Leadership Role
BOSTON, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in…
NMD Pharma publishes new data on the role of ClC-1 inhibition in Charcot-Marie-Tooth in the Annals of Clinical and Translational Neurology
NMD Pharma publishes new data on the role of ClC-1 inhibition in…
SBI Life’s ‘Apne Iraadon Ko Smart Guarantee Do’ TVC highlights the role of financial security in instilling confidence to pursue individual aspirations
The TVC campaign highlights the intangible benefits of 'SBI Life - Smart Platina…
SBI Life’s ‘Apne Iraadon Ko Smart Guarantee Do’ TVC highlights the role of financial security in instilling confidence to pursue individual aspirations
The TVC campaign highlights the intangible benefits of 'SBI Life - Smart Platina…
SBI Life’s ‘Apne Iraadon Ko Smart Guarantee Do’ TVC highlights the role of financial security in instilling confidence to pursue individual aspirations
The TVC campaign highlights the intangible benefits of 'SBI Life - Smart Platina…
SBI Life’s ‘Apne Iraadon Ko Smart Guarantee Do’ TVC highlights the role of financial security in instilling confidence to pursue individual aspirations
The TVC campaign highlights the intangible benefits of 'SBI Life - Smart Platina…
Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC)
Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients…
TerrAscend Appoints Lynn Gefen to Expanded Role of Chief People Officer
TORONTO, Nov. 26, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the…
Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC)
Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients…